COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Coronavirus Drug Discovery - 1st Edition - ISBN: 9780323851565

Coronavirus Drug Discovery

1st Edition

SARS-CoV-2 (Covid 19) Prevention, Diagnosis, and Treatment

Editor: Chukwuebuka Egbuna
Paperback ISBN: 9780323851565
Imprint: Elsevier
Page Count: 420
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Coronavirus Drug Discovery: SARS-CoV-2 (Covid 19) Prevention, Diagnosis, and Treatment presents comprehensive information on antiviral drug discovery from medicinal plants, animals, marine organisms and microorganisms. This book present special chapters on the COVID-19 disease outbreak and detailed information on drug discovery for the COVID-19 virus, including its diagnosis and prevention strategies. Subsequent chapters present drug discovery opportunities for the treatment and management of respiratory viral diseases, gastrointestinal viral diseases, exanthematous viral diseases, hepatic viral diseases, cutaneous viral diseases, hemorrhagic viral diseases and neurologic viral diseases.

The book's contributors are specialists from key institutions around the world, making this a key resource for drug developers, medicinal chemists, public health scientists, molecular biologists, biochemists, and toxicologists, among others.

Key Features

  • Details the various natural bioactive compounds for antiviral drug discoveries surrounding treatments for the coronavirus
  • Discuses recent drug discovery for covid-19 treatment and drug discovery from natural sources
  • Focuses on the discovery of drugs against acute viral diseases of world importance
  • Reviews recent advances in research tools for the discovery of new antiviral drugs

Readership

Researchers in organic and medicinal chemistry including drug developers, medicinal chemists, toxicologists, analytical chemists. Researchers in pharmaceutical and biotech industries

Table of Contents

  1. Antiviral drug discovery from medicinal plants
    2. Antiviral drug discovery from animals
    3. Antiviral drug discovery from marine organisms
    4. Antiviral drug discovery from microorganisms
    5. Coronavirus virology, treatment and drug discovery update
    6. Coronavirus outbreak: The COVID-19 episode and conspiracy theories
    7. Covid-19 signs and symptoms, diagnosis and prevention strategies
    8. Application of computational tools for coronavirus drug discovery
    9. Application of nanotechnology in tackling COVID-19
    10. Drug discovery update for respiratory viral diseases
    11. Drug discovery update for gastrointestinal viral diseases
    12. Drug discovery update for exanthematous viral diseases
    13. Drug discovery update for hepatic viral diseases
    14. Drug discovery update for cutaneous viral diseases
    15. Drug discovery update for hemorrhagic viral diseases
    16. Drug discovery update for neurologic viral diseases
    17. Tools and assays in antiviral drug discovery
    18. Systematic review on bioactives with the most potent antiviral properties

Details

No. of pages:
420
Language:
English
Copyright:
© Elsevier 2021
Imprint:
Elsevier
Paperback ISBN:
9780323851565

About the Editor

Chukwuebuka Egbuna

Chukwuebuka Egbuna is a chartered chemist, a chemical analyst, and an academic researcher. He is a member of the Institute of Chartered Chemists of Nigeria (ICCON), the Nigerian Society of Biochemistry and Molecular Biology (NSBMB), the Society of Quality Assurance (SQA) (USA), and the Royal Society of Chemistry (RSC) (United Kingdom). Egbuna is also an editor of new Elsevier series on Drug Discovery Update. The series includes books, monographs and edited collections from all areas of drug discovery, including emerging therapeutic claims for the treatment of diseases. He has been engaged in a number of roles at New Divine Favor Pharmaceutical Industry Limited, Akuzor Nkpor, Anambra State, Nigeria, and Chukwuemeka Odumegwu Ojukwu University (COOU) in Nigeria. He has collaboratively worked and published quite a number of research articles in the area of phytochemistry, nutrition and toxicology and related areas. He is a reviewer and editorial board member of various journals, including serving as a website administrator for the Tropical Journal of Applied Natural Sciences (TJANS), a journal of the faculty of Natural Sciences, COOU and as an advisory board member under toxicology for the book publisher, Cambridge Scholar Publishing. His primary research interests are in phytochemistry, nutrition and toxicology, food and medicinal chemistry, and analytical biochemistry.

Affiliations and Expertise

Department of Biochemistry, Chukwuemeka Odumegwu Ojukwu University, Anambra State, Nigeria

Ratings and Reviews